Benzinga | Aug 17, 2021 12:05PM EDT

Aegis Capital Maintains Buy on MediWound, Lowers Price Target to $9

Aegis Capital maintains MediWound (NASDAQ:MDWD) with a Buy and lowers the price target from $10 to $9.